Lista de obras - Tanja Schneider - Dominio Público Uruguay

A new antibiotic kills pathogens without detectable resistance

artículo científico publicado en 2015

An oldie but a goodie - cell wall biosynthesis as antibiotic target pathway

artículo científico publicado en 2009

Analysis of the Staphylococcus aureus capsule biosynthesis pathway in vitro: characterization of the UDP-GlcNAc C6 dehydratases CapD and CapE and identification of enzyme inhibitors.

artículo científico publicado en 2014

Auxiliary factors: a chink in the armor of MRSA resistance to β-lactam antibiotics

artículo científico

Characterization of co-translationally formed nanodisc complexes with small multidrug transporters, proteorhodopsin and with the E. coli MraY translocase.

artículo científico publicado en 2012

Characterization of serine hydroxymethyltransferase GlyA as a potential source of D-alanine in Chlamydia pneumoniae.

artículo científico publicado en 2014

Coordination of capsule assembly and cell wall biosynthesis in Staphylococcus aureus

artículo científico publicado en 2019

Copsin, a novel peptide-based fungal antibiotic interfering with the peptidoglycan synthesis.

artículo científico publicado en 2014

Cyclic lipopeptides as antibacterial agents - potent antibiotic activity mediated by intriguing mode of actions

artículo científico publicado en 2013

Diastereoselective synthesis of a bicyclic β-lactam with penicillin G-like spectrum of activity by carbonylation of an acyclic diaminocarbene

scientific article published on 21 January 2014

Erratum: A new antibiotic kills pathogens without detectable resistance

artículo científico publicado en 2015

Eurocin, a New Fungal Defensin: STRUCTURE, LIPID BINDING, AND ITS MODE OF ACTION

artículo científico publicado en 2012

Feglymycin is an inhibitor of the enzymes MurA and MurC of the peptidoglycan biosynthesis pathway

artículo científico publicado en 2011

Functional conservation of the lipid II biosynthesis pathway in the cell wall-less bacteria Chlamydia and Wolbachia: why is lipid II needed?

artículo científico publicado en 2009

Identification and in vitro analysis of the GatD/MurT enzyme-complex catalyzing lipid II amidation in Staphylococcus aureus

artículo científico publicado en 2012

In vitro assembly of a complete, pentaglycine interpeptide bridge containing cell wall precursor (lipid II-Gly5) of Staphylococcus aureus

artículo científico publicado en 2004

Insight into invertebrate defensin mechanism of action: oyster defensins inhibit peptidoglycan biosynthesis by binding to lipid II.

artículo científico publicado en 2010

Insights into in vivo activities of lantibiotics from gallidermin and epidermin mode-of-action studies

artículo científico publicado en 2006

Interaction of type A lantibiotics with undecaprenol-bound cell envelope precursors

artículo científico publicado en 2012

Lipid II and other bactoprenol-bound cell wall precursors as drug targets.

artículo científico publicado en 2010

Lipid II-based antimicrobial activity of the lantibiotic plantaricin C.

artículo científico publicado en 2006

Lipodepsipeptide Empedopeptin Inhibits Cell Wall Biosynthesis through Ca2+-dependent Complex Formation with Peptidoglycan Precursors ⬇️

artículo científico publicado el 18 de abril de 2012

Localization and functional analysis of PepI, the immunity peptide of Pep5-producing Staphylococcus epidermidis strain 5.

artículo científico publicado en 2004

Mechanisms of daptomycin resistance in Staphylococcus aureus: role of the cell membrane and cell wall

artículo científico publicado en 2012

MprF-mediated biosynthesis of lysylphosphatidylglycerol, an important determinant in staphylococcal defensin resistance.

artículo científico publicado en 2004

Murgocil is a highly bioactive staphylococcal-specific inhibitor of the peptidoglycan glycosyltransferase enzyme MurG.

artículo científico publicado en 2013

Plectasin, a fungal defensin, targets the bacterial cell wall precursor Lipid II.

artículo científico publicado en 2010

Preparative scale cell-free production and quality optimization of MraY homologues in different expression modes

artículo científico publicado en 2011

Requirement of lipid II biosynthesis for cell division in cell wall-less Wolbachia, endobacteria of arthropods and filarial nematodes

artículo científico publicado en 2013

Specific interaction of the unmodified bacteriocin Lactococcin 972 with the cell wall precursor lipid II.

artículo científico publicado en 2008

Structural variations of the cell wall precursor lipid II and their influence on binding and activity of the lipoglycopeptide antibiotic oritavancin

artículo científico publicado en 2014

The Lantibiotic NAI-107 Binds to Bactoprenol-bound Cell Wall Precursors and Impairs Membrane Functions

artículo científico publicado en 2014

The nonantibiotic small molecule cyslabdan enhances the potency of β-lactams against MRSA by inhibiting pentaglycine interpeptide bridge synthesis

artículo científico publicado en 2012

Visualizing the mode of action and supramolecular assembly of teixobactin analogues in <i>Bacillus subtilis</i>

artículo científico publicado en 2022

Lista de obras de Tanja Schneider

A new antibiotic kills pathogens without detectable resistance

An oldie but a goodie - cell wall biosynthesis as antibiotic target pathway

Analysis of the Staphylococcus aureus capsule biosynthesis pathway in vitro: characterization of the UDP-GlcNAc C6 dehydratases CapD and CapE and identification of enzyme inhibitors.

Auxiliary factors: a chink in the armor of MRSA resistance to β-lactam antibiotics

Characterization of co-translationally formed nanodisc complexes with small multidrug transporters, proteorhodopsin and with the E. coli MraY translocase.

Characterization of serine hydroxymethyltransferase GlyA as a potential source of D-alanine in Chlamydia pneumoniae.

Coordination of capsule assembly and cell wall biosynthesis in Staphylococcus aureus

Copsin, a novel peptide-based fungal antibiotic interfering with the peptidoglycan synthesis.

Cyclic lipopeptides as antibacterial agents - potent antibiotic activity mediated by intriguing mode of actions

Diastereoselective synthesis of a bicyclic β-lactam with penicillin G-like spectrum of activity by carbonylation of an acyclic diaminocarbene

Erratum: A new antibiotic kills pathogens without detectable resistance

Eurocin, a New Fungal Defensin: STRUCTURE, LIPID BINDING, AND ITS MODE OF ACTION

Feglymycin is an inhibitor of the enzymes MurA and MurC of the peptidoglycan biosynthesis pathway

Functional conservation of the lipid II biosynthesis pathway in the cell wall-less bacteria Chlamydia and Wolbachia: why is lipid II needed?

Identification and in vitro analysis of the GatD/MurT enzyme-complex catalyzing lipid II amidation in Staphylococcus aureus

In vitro assembly of a complete, pentaglycine interpeptide bridge containing cell wall precursor (lipid II-Gly5) of Staphylococcus aureus

Insight into invertebrate defensin mechanism of action: oyster defensins inhibit peptidoglycan biosynthesis by binding to lipid II.

Insights into in vivo activities of lantibiotics from gallidermin and epidermin mode-of-action studies

Interaction of type A lantibiotics with undecaprenol-bound cell envelope precursors

Lipid II and other bactoprenol-bound cell wall precursors as drug targets.

Lipid II-based antimicrobial activity of the lantibiotic plantaricin C.

Lipodepsipeptide Empedopeptin Inhibits Cell Wall Biosynthesis through Ca2+-dependent Complex Formation with Peptidoglycan Precursors ⬇️

Localization and functional analysis of PepI, the immunity peptide of Pep5-producing Staphylococcus epidermidis strain 5.

Mechanisms of daptomycin resistance in Staphylococcus aureus: role of the cell membrane and cell wall

MprF-mediated biosynthesis of lysylphosphatidylglycerol, an important determinant in staphylococcal defensin resistance.

Murgocil is a highly bioactive staphylococcal-specific inhibitor of the peptidoglycan glycosyltransferase enzyme MurG.

Plectasin, a fungal defensin, targets the bacterial cell wall precursor Lipid II.

Preparative scale cell-free production and quality optimization of MraY homologues in different expression modes

Requirement of lipid II biosynthesis for cell division in cell wall-less Wolbachia, endobacteria of arthropods and filarial nematodes

Specific interaction of the unmodified bacteriocin Lactococcin 972 with the cell wall precursor lipid II.

Structural variations of the cell wall precursor lipid II and their influence on binding and activity of the lipoglycopeptide antibiotic oritavancin

The Lantibiotic NAI-107 Binds to Bactoprenol-bound Cell Wall Precursors and Impairs Membrane Functions

The nonantibiotic small molecule cyslabdan enhances the potency of β-lactams against MRSA by inhibiting pentaglycine interpeptide bridge synthesis

Visualizing the mode of action and supramolecular assembly of teixobactin analogues in <i>Bacillus subtilis</i>